Telegram Adds INJ to Its Wallet
This update makes it easier than ever for Telegram users to dive into Injective without needing extra apps. Telegram's built-in wallet has already supported major cryptocurrencies like Bitcoin (BTC) and Toncoin (TON).
Keep up with what's happening in the crypto world in real-time.
This update makes it easier than ever for Telegram users to dive into Injective without needing extra apps. Telegram's built-in wallet has already supported major cryptocurrencies like Bitcoin (BTC) and Toncoin (TON).
The crypto market has made a strong start to the week, with cryptocurrencies registering substantial increases. As a result, the crypto market cap has jumped almost 3% and currently sits at $2.83 trillion.
The crypto market rallied after the Federal Reserve decided to keep interest rates unchanged between 4.25% and 4.50% after the Federal Open Market Committee (FOMC) meeting. The Federal Reserve also stated it sees two rate cuts coming in 2025.
This marks a game-changing moment in the world of DeFi. It offers users the ability to trade fully onchain stocks 24/7 with no middlemen.
The omni-chain solution, which counts Brevan Howard and Hamilton Lane as early partners, is live on several chains.
The crypto market continued its upward trajectory, with the market cap increasing by over 4% to reclaim the $3 trillion mark. Most cryptocurrencies traded in positive territory, and Bitcoin (BTC) reclaimed the $90,000 level after an increase of nearly 6% over the past 24 hours.
The crypto market fell back into the red as its market capitalization dropped nearly 11% to $2.75 trillion, erasing all the gains made on Sunday after President Donald Trump's crypto reserve announcement. Sunday's rally began fading on Monday, with Bitcoin (BTC) and other altcoins sliding back to pre-weekend levels.
Its subsidiary, Deutsche Telekom MMS, is now a validator for the Injective blockchain. This marks another milestone in merging traditional industries with decentralized finance (DeFi).
Deutsche Telekom MMS partners with Injective blockchain as a new validator, enhancing Web3 infrastructure. Partnership aims to improve enterprise adoption of blockchain technology, fostering true decentralization.
Deutsche Telekom's subsidiary, MMS, has taken a bold step into the blockchain world by becoming a validator for Injective, an interoperable Layer-1 blockchain. This move strengthens Injective's network security and decentralization. It also marks another milestone in Deutsche Telekom's growing Web3 presence. This collaboration showcases a blend of traditional enterprise and cutting-edge blockchain technology.
Deutsche Telekom, a telecommunications giant valued at more than $180 billion, has strengthened its presence in the crypto and blockchain space by partnering with Injective. On Feb.
Deutsche Telekom MMS expands its Web3 footprint by becoming a validator for Injective, ensuring the blockchain's security, decentralization, and reliability for digital asset trading, tokenization, and payments. The post Deutsche Telekom Becomes a Validator for Injective appeared first on Cryptonews.
TL;DR Deutsche Telekom joins Injective as a validator, marking a significant step towards bridging traditional infrastructure with blockchain technology. The collaboration highlights Deutsche Telekom's commitment to Web3, expanding its involvement in the crypto space. This partnership strengthens Injective's position as one of the most efficient and institutional-friendly Layer 1 networks.
The move marks Deutsche's latest step into the crypto space, which includes forays into validating networks and mining bitcoins.
The price of Injective (INJ) has garnered significant attention in the cryptocurrency space, particularly after the rise of artificial intelligence (AI) applications. As of now, the live price of Injective stands at $14.61, with its market capitalization reaching $1.53 billion.
Story Highlights The live price of the Injective token is The INJ price could hit a high of $56.12 in 2025. With a potential surge, Injective may hit $208.99 by 2030. Launched in November 2021, alongside a $120M incentive program called Astro, the Injective Protocol plays an important role in the Artificial Intelligence (AI) category.
Injective (INJ) has experienced a significant decline since reaching its all-time high (ATH) of $53 in March 2024. Since then, the altcoin has dropped by an alarming 73%, with its price hovering near a 15-month low.
Injective is hovering near a 15-month low, but a key breakout pattern could set the stage for a potential rebound.
Injective is taking another step toward narrowing the gap between traditional finance and decentralized finance by bringing stocks of the largest publicly traded companies on-chain.
Injective Labs launches an on-chain S&P 500 index, enabling investors to, for the first time, gain exposure to SPY with 24/7 access. The post Injective Launches S&P 500 Index On-Chain, Enables TradFi Access on DeFi appeared first on Cryptonews.
Even after a major upgrade, INJ's price has barely moved, gaining only 2% in a day.
Injective (INJ)announces a new brand identity, marking a significant evolution as it defines its future direction. The rebranding aligns with recent achievements and sets the stage for upcoming initiatives.
Injective (INJ)introduces InjScan, a revamped blockchain explorer enhancing user experience with new features like advanced smart contract tools and improved data visualization.
Injective (INJ)Hub V2 introduces a revamped design and improved user experience, offering seamless access to the Injective ecosystem. Discover new features including enhanced onboarding and streamlined navigation.